After a contentious meeting, vaccine advisers for the US Centers for Disease Control and Prevention (CDC) voted on Thursday to delay a vote on restricting hepatitis B vaccination for infants until Friday.

The meeting of the advisory committee on immunization practices (ACIP) turned confrontational at times before one member introduced a motion to delay the vote, which passed by six to three, to give advisers time to examine the wording before taking a vote.

In the unprecedented meeting, the vaccine advisers debated restricting access to the hepatitis B vaccine for infants – a significant step toward limiting safe and effective shots given for decades.

No new evidence on harms from the vaccine, which has been given to 1.4 billion people for more than three decades with a stellar safety r

See Full Page